(Circulation. 2001;103:65.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Hypertrophic Cardiomyopathy Caused by a Novel 
-Tropomyosin Mutation (V95A) Is Associated With Mild Cardiac Phenotype, Abnormal Calcium Binding to Troponin, Abnormal Myosin Cycling, and Poor Prognosis
From the Department of Medicine, Baylor College of Medicine (A.K., L.L.B., R.R.), Houston, Tex; Departments of Internal Medicine (L.S.T., J.S., C.B.) and Biochemistry (L.S.T.), University of Iowa, Iowa City, Iowa; Department of Physiology (N.B., E.H.), University of California, Los Angeles; and National Heart, Lung, and Blood Institute (A.E.A., A.O., L.F.), National Institutes of Health, Bethesda, Md.
Background—We
report hypertrophic cardiomyopathy (HCM) in a
Spanish-American family caused by a novel 
-tropomyosin
(TPM1) mutation and examine the
pathogenesis of the clinical disease by characterizing functional
defects in the purified mutant protein.
Methods and Results—HCM was linked to the TPM1 gene (logarithm of the odds [LOD] score 3.17). Sequencing and restriction digestion analysis demonstrated a TPM1 mutation V95A that cosegregated with HCM. The mutation has been associated with 13 deaths in 26 affected members (11 sudden deaths and 2 related to heart failure), with a cumulative survival rate of 73±10% at the age of 40 years. Left ventricular wall thickness (mean 16±6 mm) and disease penetrance (53%) were similar to those for the ß-myosin mutations L908V and G256E previously associated with a benign prognosis. Left ventricular hypertrophy was milder than with the ß-myosin mutation R403Q, but the prognosis was similarly poor. With the use of recombinant tropomyosins, we identified several functional alterations at the protein level. The mutation caused a 40% to 50% increase in calcium affinity in regulated thin filament–myosin subfragment-1 (S1) MgATPase assays, a 20% decrease in MgATPase rates in the presence of saturating calcium, a 5% decrease in unloaded shortening velocity in in vitro motility assays, and no change in cooperative myosin S1 binding to regulated thin filaments.
Conclusions—In contrast to other reported TPM1 mutations, V95A-associated HCM exhibits unusual features of mild phenotype but poor prognosis. Both myosin cycling and calcium binding to troponin are abnormal in the presence of the mutant tropomyosin. The genetic diagnosis afforded by this mutation will be valuable in the management of HCM.
Key Words: cardiomyopathy • genetics • death, sudden • prognosis
This article has been cited by other articles:
 |
|
 |
|
  F. W. Friedrich, P. Bausero, Y. Sun, A. Treszl, E. Kramer, D. Juhr, P. Richard, K. Wegscheider, K. Schwartz, D. Brito, et al. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy Eur. Heart J., July 1, 2009; 30(13): 1648 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dweck, N. Hus, and J. D. Potter Challenging Current Paradigms Related to Cardiomyopathies: ARE CHANGES IN THE Ca2+ SENSITIVITY OF MYOFILAMENTS CONTAINING CARDIAC TROPONIN C MUTATIONS (G159D AND L29Q) GOOD PREDICTORS OF THE PHENOTYPIC OUTCOMES? J. Biol. Chem., November 28, 2008; 283(48): 33119 - 33128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Baggish, K. Yared, F. Wang, R. B. Weiner, A. M. Hutter Jr., M. H. Picard, and M. J. Wood The impact of endurance exercise training on left ventricular systolic mechanics Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1109 - H1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ochala, M. Li, M. Ohlsson, A. Oldfors, and L. Larsson Defective regulation of contractile function in muscle fibres carrying an E41K {beta}-tropomyosin mutation J. Physiol., June 15, 2008; 586(12): 2993 - 3004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Morimoto Sarcomeric proteins and inherited cardiomyopathies Cardiovasc Res, March 1, 2008; 77(4): 659 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. M. Arteaga, R. John Solaro, S. B. Liggett, and D. F. Wieczorek Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H949 - H958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Binder, S. R. Ommen, B. J. Gersh, S. L. Van Driest, A. J. Tajik, R. A. Nishimura, and M. J. Ackerman Echocardiography-Guided Genetic Testing in Hypertrophic Cardiomyopathy: Septal Morphological Features Predict the Presence of Myofilament Mutations Mayo Clin. Proc., April 1, 2006; 81(4): 459 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wernicke, C. Thiel, C. M. Duja-Isac, K. V. Essin, M. Spindler, D. J. R. Nunez, R. Plehm, N. Wessel, A. Hammes, R.-J. Edwards, et al. {alpha}-Tropomyosin mutations Asp175Asn and Glu180Gly affect cardiac function in transgenic rats in different ways Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R685 - R695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Canton, I. Neverova, R. Menabo, J. Van Eyk, and F. Di Lisa Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H870 - H877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Heller, M. Nili, E. Homsher, and L. S. Tobacman Cardiomyopathic Tropomyosin Mutations That Increase Thin Filament Ca2+ Sensitivity and Tropomyosin N-domain Flexibility J. Biol. Chem., October 24, 2003; 278(43): 41742 - 41748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Van Driest, E. G. Ellsworth, S. R. Ommen, A. J. Tajik, B. J. Gersh, and M. J. Ackerman Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy * Note Added in Proof Circulation, July 29, 2003; 108(4): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kohler, Y. Chen, B. Brenner, A. M. Gordon, T. Kraft, D. A. Martyn, M. Regnier, A. J. Rivera, C.-K. Wang, and P. B. Chase Familial hypertrophic cardiomyopathy mutations in troponin I (K183{Delta}, G203S, K206Q) enhance filament sliding Physiol Genomics, July 7, 2003; 14(2): 117 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kaynak, A. von Heydebreck, S. Mebus, D. Seelow, S. Hennig, J. Vogel, H.-P. Sperling, R. Pregla, V. Alexi-Meskishvili, R. Hetzer, et al. Genome-Wide Array Analysis of Normal and Malformed Human Hearts Circulation, May 20, 2003; 107(19): 2467 - 2474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Jongbloed, C. L. Marcelis, P. A. Doevendans, J. M. Schmeitz-Mulkens, W. G. Van Dockum, J. P. Geraedts, and H. J. Smeets Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Marian On predictors of sudden cardiac death in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 994 - 996. [Full Text] [PDF]
|
|
|
|
|
|
A. Hinkle and L. S. Tobacman Folding and Function of the Troponin Tail Domain. EFFECTS OF CARDIOMYOPATHIC TROPONIN T MUTATIONS J. Biol. Chem., January 3, 2003; 278(1): 506 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pieples, G. Arteaga, R. J. Solaro, I. Grupp, J. N. Lorenz, G. P. Boivin, G. Jagatheesan, E. Labitzke, P. P. deTombe, J. P. Konhilas, et al. Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca2+ activation Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1344 - H1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Roberts and U. Sigwart New Concepts in Hypertrophic Cardiomyopathies, Part I Circulation, October 23, 2001; 104(17): 2113 - 2116. [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Brown, K.-H. Kim, G. Jun, N. J. Greenfield, R. Dominguez, N. Volkmann, S. E. Hitchcock-DeGregori, and C. Cohen Deciphering the design of the tropomyosin molecule PNAS, June 28, 2001; (2001) 131219198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Brown, K.-H. Kim, G. Jun, N. J. Greenfield, R. Dominguez, N. Volkmann, S. E. Hitchcock-DeGregori, and C. Cohen Deciphering the design of the tropomyosin molecule PNAS, July 17, 2001; 98(15): 8496 - 8501. [Abstract] [Full Text] [PDF]
|
|